Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)
CNY 16.08
(0.06%)
CNY 16.08
(0.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 64.42 Million | 40.71 Million | 74.46 Million | 333.2 Million | 58.55 Million | 88.68 Million |
| Net Income | -54.2 Million | 30.44 Million | 71.82 Million | 189.97 Million | 37.75 Million | 42.58 Million |
| Depreciation & Amortization | 72.61 Million | 68.24 Million | 71.31 Million | 69.72 Million | 51.73 Million | 33.02 Million |
| Deferred income taxes | 314.85 Thousand | -1.08 Million | 594.81 Thousand | 3.25 Million | 970.97 Thousand | 795.55 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -14.22 Million | -57.91 Million | -73.03 Million | 30.07 Million | -58.45 Million | 2.79 Million |
| Other non-cash items | 60.23 Million | -54.67 Thousand | 4.35 Million | 43.42 Million | 27.51 Million | 10.27 Million |
| Investing Cash Flow | -241.51 Million | -88.33 Million | 2.54 Million | -122.15 Million | -248.75 Million | -82.65 Million |
| Investments in PPE | -245.92 Million | -63.25 Million | -99.96 Million | -85.15 Million | -185.88 Million | -144.51 Million |
| Acquisitions | -2.86 Million | -7 Million | 933.67 Thousand | 736.29 Thousand | 187.3 Million | -14.83 Million |
| Investment purchases | -25 Million | -370 Million | -238 Million | -199.2 Million | -96 Million | -15.5 Million |
| Sales/Maturities of investments | 32.05 Million | 351.39 Million | 339.57 Million | 160.29 Million | 31.69 Million | 93.08 Million |
| Other Investing Activities | 218.12 Thousand | 533.04 Thousand | 0.25 | 1.16 Million | -185.88 Million | -887.02 Thousand |
| Financing Cash Flow | 176.98 Million | -156.87 Million | -22.71 Million | -52.06 Million | 214.59 Million | 9.45 Million |
| Debt repayment | -205.5 Million | -218.58 Million | -314.63 Million | -305.25 Million | -259.35 Million | -130 Million |
| Dividends payments | -10.27 Million | -23.96 Million | -59.91 Million | -14.67 Million | -13.44 Million | -26.45 Million |
| Common Stock Repurchased | -8.96 Million | - | - | - | - | - |
| Common Stock Issuance | -1.61 Million | - | - | - | - | - |
| Other Financing Activities | -14.33 Million | 89.13 Million | 357.38 Million | 272 Million | 495.15 Million | 165.9 Million |
| Accounts receivables | 36.49 Million | 10.76 Million | 250.68 Million | -15.73 Million | -25.26 Million | 24.93 Million |
| Accounts payables | -75.11 Million | 20.34 Million | -261.26 Million | 49.15 Million | 41.7 Million | -9.73 Million |
| Inventory | 23.37 Million | -87.93 Million | -63.04 Million | -6.59 Million | -75.86 Million | -13.2 Million |
| Other working capital | 1.01 Million | -1.08 Million | 594.81 Thousand | 3.25 Million | 970.97 Thousand | 16 Million |
| Cash at beginning of period | 303.35 Million | 490.02 Million | 442.4 Million | 301.33 Million | 274.21 Million | 253.38 Million |
| Cash at end of period | 305.86 Million | 303.35 Million | 490.02 Million | 442.4 Million | 301.33 Million | 274.21 Million |
| Capital Expenditure | -245.92 Million | -63.25 Million | -99.96 Million | -85.15 Million | -185.88 Million | -144.51 Million |
| Effect of forex changes on cash | 2.62 Million | 17.82 Million | -6.67 Million | -17.9 Million | 2.73 Million | 5.35 Million |
| Net cash flow / Change in cash | 2.51 Million | -186.66 Million | 47.61 Million | 141.06 Million | 27.11 Million | 20.83 Million |
| Free Cash Flow | -181.5 Million | -22.54 Million | -25.5 Million | 248.04 Million | -127.32 Million | -55.82 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.18 Million | 12.68 Million | 3.81 Million | -50.37 Million | -54.2 Million | 2.64 Million |
| Depreciation & Amortization | - | 19.43 Million | 19.43 Million | 72.61 Million | 72.61 Million | -35.97 Million |
| Deferred income taxes | - | - | - | - | 314.85 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 24.23 Million | - | 60.88 Million | -14.22 Million | 50.91 Million |
| Other non-cash items | 64.55 Million | 27.4 Million | -9.9 Million | -34.06 Million | 60.23 Million | 21.05 Million |
| Investing Cash Flow | -150.04 Million | 17.77 Million | -86.26 Million | -91.59 Million | -241.51 Million | -75.24 Million |
| Investments in PPE | -40.99 Million | -45.23 Million | -46.28 Million | -81.04 Million | -245.92 Million | -75.15 Million |
| Acquisitions | 155.79 Thousand | 2580.00 | 25.89 Thousand | -148.05 Thousand | -2.86 Million | -2.38 Million |
| Investment purchases | -149.28 Million | 20 Million | -62 Million | -20 Million | -25 Million | 2.38 Million |
| Sales/Maturities of investments | 40.08 Million | 43 Million | 22 Million | 9.01 Million | 32.05 Million | 2.29 Million |
| Other Investing Activities | 155.79 Thousand | 64.24 Million | -38.28 Million | 579.36 Thousand | 218.12 Thousand | -2.38 Million |
| Financing Cash Flow | 13.54 Million | -75.38 Million | 33.43 Million | 47.79 Million | 176.98 Million | 48.84 Million |
| Debt repayment | -15.69 Million | -60.9 Million | -47 Million | -57.5 Million | -205.5 Million | -51 Million |
| Dividends payments | -1.71 Million | -10.15 Million | -454.77 Thousand | -10.27 Million | -10.27 Million | -518.77 Thousand |
| Common Stock Repurchased | 13.11 Million | -13.11 Million | - | -8.96 Million | -8.96 Million | 5.06 Million |
| Common Stock Issuance | - | - | - | -1.61 Million | -1.61 Million | -56.06 Million |
| Other Financing Activities | -433.89 Thousand | 9.18 Million | -13.56 Million | -7.26 Million | -14.33 Million | 151.36 Million |
| Accounts receivables | - | 24.2 Million | - | 36.49 Million | 36.49 Million | 77.34 Million |
| Accounts payables | - | - | - | - | -75.11 Million | - |
| Inventory | - | 33.77 Thousand | - | 23.37 Million | 23.37 Million | -26.42 Million |
| Other working capital | - | - | - | 1.01 Million | 1.01 Million | - |
| Cash at beginning of period | 212.86 Million | 271.8 Million | 326.01 Million | 300.42 Million | 303.35 Million | 286.86 Million |
| Cash at end of period | 145.54 Million | 237.21 Million | 271.8 Million | 305.86 Million | 305.86 Million | 300.42 Million |
| Capital Expenditure | -40.99 Million | -45.23 Million | -46.28 Million | -81.04 Million | -245.92 Million | -75.15 Million |
| Effect of forex changes on cash | -470.92 Thousand | 2.55 Million | 334.42 Thousand | 187.41 Thousand | 2.62 Million | 1.31 Million |
| Net cash flow / Change in cash | -67.31 Million | -34.58 Million | -54.21 Million | 5.44 Million | 2.51 Million | 13.55 Million |
| Free Cash Flow | 28.73 Million | -24.58 Million | -52.38 Million | -31.99 Million | -181.5 Million | -36.52 Million |
1438
206650
BFAM
GASS
7774
KNG